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Abstract
Background—Tobacco smoke, diet and indoor/outdoor air pollution, all major sources of 
polycyclic aromatic hydrocarbons (PAHs), have been associated with breast cancer. Aberrant 
methylation may be an early event in carcinogenesis, but whether PAHs influence the epigenome 
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is unclear, particularly in breast tissue where methylation may be most relevant. We aimed to 
evaluate the role of methylation in the association between PAHs and breast cancer.
Methods—In a population-based case-control study, we measured promoter methylation of 13 
breast cancer-related genes in breast tumor tissue (n=765–851 cases) and global methylation in 
peripheral blood (1,055 cases/1,101 controls). PAH sources (current active smoking, residential 
environmental tobacco smoke (ETS), vehicular traffic, synthetic log burning, and grilled/smoked 
meat intake) were evaluated separately. Logistic regression was used to estimate adjusted odds 
ratios (ORs) and 95% confidence intervals (CIs).
Results—When comparing methylated versus unmethylated genes, synthetic log use was 
associated with increased ORs for CDH1 (OR=2.26, 95%CI=1.06–4.79), HIN1 (OR=2.14, 
95%CI=1.34–3.42) and RARβ (OR=1.80, 95%CI=1.16–2.78) and decreased ORs for BRCA1 
(OR=0.44, 95%CI=0.30–0.66). Residential ETS was associated with decreased ORs for ESR1 
(OR=0.74, 95%CI=0.56–0.99) and CCND2 methylation (OR=0.65, 95%CI=0.44–0.96). Current 
smoking and vehicular traffic were associated with decreased ORs for DAPK (OR=0.53, 
95%CI=0.28–0.99) and increased ORs for TWIST1 methylation (OR=2.79, 95%CI=1.24–6.30), 
respectively. In controls, synthetic log use was inversely associated with LINE-1 (OR=0.59, 
95%CI=0.41–0.86).
Discussion—PAH sources were associated with hypo- and hypermethylation at multiple 
promoter regions in breast tumors and LINE-1 hypomethylation in blood of controls. Methylation 
may be a potential biologic mechanism for the associations between PAHs and breast cancer 
incidence.
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1.1 Introduction
Polycyclic aromatic hydrocarbons (PAHs) are established carcinogens to the lung (IARC 
2010), but their relationship with breast cancer is not as well studied. PAH biomarkers, 
which tend to reflect recent exposure, have been associated with breast cancer incidence 
(Gammon et al. 2004b). Additionally, PAHs induce mammary tumors in laboratory animals 
(Hecht 2002). PAHs are ubiquitous pollutants that form as a combustion by-product of 
organic material (Boström et al. 2002). The major sources of PAH in the general population 
are indoor and outdoor air pollution, tobacco smoke and diet (Boström et al. 2002). Elevated 
associations with breast cancer incidence have been observed with the main sources of PAH 
exposure, including active cigarette smoking (Gaudet et al. 2013), long-term environmental 
tobacco smoke (ETS) (Gammon et al. 2004a; Morabia et al. 1996), indoor air pollution from 
burning synthetic logs (White et al. 2014), outdoor air pollution (Hystad et al. 2015; 
Mordukhovich et al. 2015; Nie et al. 2007), and intake of grilled and smoked foods (Fu et al. 
2011; Steck et al. 2007).
Aberrant DNA methylation, an epigenetic modification, plays an important role in breast 
carcinogenesis (Xu et al. 2011; Xu et al. 2012). Higher levels of methylation at promoter 
regions can silence tumor suppressor genes and tumor tissue may be were methylation is 
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most relevant (Jones 2012). Our research team has reported that methylation at promoter 
regions of specific genes in breast tumor tissue is associated with breast cancer clinical/
pathological factors and mortality in a population-based sample (Cho et al. 2012). In 
contrast, lower levels of global methylation may confer genomic instability and increased 
mutation rates (Brennan and Flanagan 2012). Although the associations between cancer and 
global methylation have been inconclusive (Brennan and Flanagan 2012), our research 
group has previously reported an association with breast cancer for luminometric 
methylation assay (LUMA), but not for methylation of long interspersed elements-1 
(LINE-1) in white blood cells (Xu et al. 2012). DNA methylation may be altered in response 
to environment and lifestyle factors and may be a potential biologic mechanism for disease 
(Bollati and Baccarelli 2010). Other investigators have found that exposure to the PAH 
sources of tobacco smoke and air pollution may be associated with changes in DNA 
methylation patterns (Duan et al. 2013; Shenker et al. 2013).
For the current study, we aimed to better understand the role methylation plays in the PAH 
and breast cancer association. We first aimed to examine whether five individual PAH 
sources, previously found to be modestly associated with breast cancer incidence (current 
active cigarette smoking (Gammon et al. 2004a), long-term residential ETS (Gammon et al. 
2004a), total grilled/smoked food intake (Steck et al. 2007), residential burning of synthetic 
logs (White et al. 2014) and high vehicular traffic exposure (Mordukhovich et al. 2015)), 
were also associated with promoter methylation status in a panel of 13-breast cancer related 
genes measured in the tumor tissue of a population-based sample of women with breast 
cancer. We also aimed to investigate whether these same PAH sources were associated with 
global methylation in a population-based sample of women without breast cancer, using two 
independent global methylation markers, LINE-1 and LUMA, measured in peripheral blood 
DNA.
1.2 Materials and Methods
Our study builds upon population-based resources from the Long Island Breast Cancer 
Study Project (LIBCSP). The parent LIBCSP methods have been previously published in 
detail (Gammon et al. 2002). Institutional Review Board approval was obtained from all 
relevant institutions.
1.2.1 Study Population
Study participants included 1,508 breast cancer cases and 1,556 controls who were English-
speaking women residing in Nassau and Suffolk counties on Long Island, New York. 
Written informed consent was obtained from all study participants.
Cases were women who had been recently diagnosed with a first primary in situ or invasive 
breast cancer between August 1st, 1996 and July 31st, 1997, and were residents of Nassau or 
Suffolk counties on Long Island, New York (NY). There were no age or race restrictions for 
case eligibility. Cases were identified using rapid case ascertainment from the pathology 
departments of all 28 hospitals on Long Island and three tertiary care hospitals in New York 
City. Diagnoses were confirmed by the physician or the medical record.
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Controls had no prior history of breast cancer and were frequency matched in 5-year age 
groups to cases based on the expected age distribution of case women. Controls were 
identified in 1996–1997 from among adult female residents of Nassau and Suffolk counties 
in NY using random digit dialing for those who were less than 65 years of age, and for those 
who were 65 years of age and greater, using the Health Care Finance Administration rosters.
Study participants ranged in age from 20 to 98 years, and most cases and controls were 
postmenopausal (68.1% and 66.3%, respectively) and identified themselves as white (93.8% 
and 91.8%, respectively); the racial distribution of our population-based sample reflects that 
of Nassau and Suffolk counties at the time of data collection (Gammon et al. 2002). Cases 
and controls had similar distributions of education and income (Gammon et al. 2002), and 
the median age at menarche was also similar (12.6 years, standard deviation (SD)=1.67; and 
12.6 years, SD=1.65, respectively). On average, controls were more likely to be parous than 
cases (89.0% versus 86.9%, respectively) (Gammon et al. 2002). Some 10% of cases and 
8% of controls reported drinking 1–2 glasses per day (15–30 grams) of alcohol, on average 
across the life course (Terry et al. 2006).
1.2.2 PAH Exposure Sources Assessment
Five PAH exposure sources were assessed. Current active smoking, residential ETS, grilled/
smoked meat intake, and synthetic log burning were assessed by a trained interviewer using 
a structured questionnaire (Gammon et al. 2004a; Steck et al. 2007; White et al. 2014); and 
vehicular traffic exposure was assessed by a validated historical geographic model (Beyea et 
al. 2006; Mordukhovich et al. 2015). Detailed LIBCSP PAH source assessment methods 
have been previously published (Gammon et al. 2004a; Mordukhovich et al. 2015; Steck et 
al. 2007; White et al. 2014). The PAH variable definitions, based on previous published 
associations with breast cancer, and total sample sizes used in the study reported here are 
described below.
Current active smoking (yes, no) was defined as smoking within the 12 months prior to the 
reference date, which was date of diagnosis for cases and date of identification for controls 
(n=1,553 controls/1,508 cases) (Gammon et al. 2004a). Participants were asked if they had 
lived with a smoking spouse to determine residential ETS exposure (yes, no) (n=1,515 
controls/1,468 cases) (Gammon et al. 2004a). Frequency of grilled/smoked meat intake was 
assessed for each of six decades across the life course, or fewer depending on age at 
diagnosis (Steck et al. 2007). Lifetime intake was defined as the average servings consumed 
per year based on quantile distributions in the controls (<33% vs ≥33% percentile or <55 
servings/year, 55+ servings/year) (n=1,515 controls/1,468 cases) (Steck et al. 2007). 
Residential stove and fireplace use was defined as using a stove/fireplace in a Long Island 
residence for at least 3 times per year and whether or not participants burned synthetic logs 
(yes, no) (n=1,541 controls/1,501 cases) (White et al. 2014). A geographic model estimated 
vehicular traffic exposure for the study participant’s residence in 1995 by incorporating 
historical United States (U.S.) vehicular PAH emissions data, information on traffic and 
transportation patterns, Long Island, NY meteorological variables and pollutant dispersion 
factors (<95th percentile, ≥95th percentile) (n=1,334 controls/1,274 cases) (Mordukhovich et 
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al. 2015). This cutpoint was previously found to best represent the association with breast 
cancer incidence (Mordukhovich et al. 2015).
As a sensitivity analysis, more refined exposure classifications for current active smoking 
(no current, current <20 pack-years, current 20+ pack-years), spouse ETS exposure in 
months (tertiles), grilled/smoked meat intake (tertiles) and vehicular traffic (<50th percentile, 
50–75th percentile, 75th-95th percentile, 95th percentile) were also evaluated.
1.2.3 Gene-specific promoter DNA methylation assessment
Promoter methylation status was measured in tumor tissue for a panel of 13 breast cancer-
related genes [adenomatous polyposis coli (APC), breast cancer 1, early onset (BRCA1), 
cyclin D2 (CCND2), E-Cadherin (CDH1), death-associated protein kinase 1 (DAPK1), 
estrogen receptor 1 (ESR1), glutathione S-transferase pi 1 (GSTP1), secretoglobin, family 
3A, member 1 (HIN1), cyclin-dependent kinase inhibitor 2A (CDKN2A), progesterone 
receptor (PGR), retinoic acid receptor, beta (RARβ , Ras association domain family member 
1 (RASSF1A) and twist homolog 1 (TWIST1)]. These genes are known to play an important 
role in breast carcinogenesis and their promoter regions are frequently methylated in breast 
tumor tissues (Xu et al. 2011). Methylation at certain CpG sites may vary by biologic 
sample type (Jones 2012) and the measurement of gene-specific methylation in the tumor 
tissue is more sensitive than measuring the same sites in circulating blood DNA (Brooks et 
al. 2009).
The methods used to determine gene-specific promoter methylation status have been 
previous published and are briefly described below (Xu et al. 2011; Xu et al. 2012). DNA 
was extracted from tumor blocks, as described in previously published methods (Xu et al. 
2009). To determine methylation levels for ESR1, PGR and BRCA1, methylation-specific 
PCR was used (Liu et al. 2003; Xu et al. 2009). The gene was determined to be methylated 
or not methylated based on whether PCR product was obtained using methylation-specific 
primers. Thus, ESR1, PGR and BRCA1 are dichotomous variables (methylated vs. 
unmethylated), as determined by the assay. Once it became available, the quantitative 
MethyLight assay was used to measure the methylation status of the remaining 10 genes 
(Eads et al. 1999; Eads et al. 2000a). Bisulfite-converted genomic DNA was amplified using 
a fluorescence-based, real-time quantitative PCR which results in a percentage methylated 
(Chomczynski and Sacchi 1987; Gibson et al. 1996). Continuous values were dichotomized 
(<4%, ≥4% methylated) to be consistent with previous published reports by our study team 
and others (Eads et al. 2000a; Xu et al. 2011). This ≥4% cutpoint for the MethyLight assay 
has been previously reported to distinguish between malignant and normal tissues and is 
indicative of repressed gene expression (Eads et al. 2000b; Ogino et al. 2006). Number of 
case samples completed and percent methylated for each promoter in LIBCSP have been 
previously reported (n=765–851 and percent methylation 3.6% −62.9%) (Xu et al. 2011).
1.2.4 Global Methylation Assessment
Two complimentary, but independent, methods were used to assess global methylation 
levels in DNA extracted from blood samples, LINE-1 and LUMA (1,055 cases/1,101 
controls) (Xu et al. 2012). The LINE-1 assay is a measure of methylation at repetitive 
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elements as a proxy measure of overall global methylation and it is hypothesized that lower 
methylation at LINE-1 may indicate increased chromosomal instability and likelihood of 
mutations (Brennan and Flanagan 2012). In contrast, the LUMA measure summarizes 
methylation levels (5-mC) at all “CCGG” sequences and thus, may be considered more 
representative of gene-specific methylation (Brennan and Flanagan 2012).
The LINE-1 assay was completed using a prevalidated pyrosequencing assay to assess 4 
CpG sites in the promoter of LINE-1 at EpigenDx (Worcester, MA, USA) as described 
previously (Xu et al. 2012). Methylation status at each of the 4 CpG loci was analyzed 
individually as a T/C single nucleotide polymorphism (SNP) using QCpG software 
(Qiagen). Methylation status data at all 4 loci were averaged to provide an overall percent 
5-mC status. The LUMA assay is expressed as a percentage obtained using the following 
equation (Bjornsson et al. 2008): methylation (%) = ((1-(HpaII∑G/∑T)/ (MspI∑G/∑T) * 
100)).
1.2.5 Hormone receptor subtype
Breast cancer subtype for the first primary was defined by estrogen/progesterone receptor 
status (ER/PR) obtained from the medical record, and was available for 65.6% of cases 
(n=990) (Gammon et al. 2002).
1.2.6 Statistical Analysis
All analyses were completed using SAS 9.3 (Cary, NC). To investigate whether the five 
PAH sources, considered separately, were associated with methylation levels, we used 
unconditional logistic regression to estimate odds ratios (ORs) and corresponding 95% 
confidence intervals (CIs). Multiplicative interaction was assessed by comparing 
multivariable models with and without cross-product terms to denote the interaction using 
an a priori alpha level of 0.05.
For examining gene-specific promoter methylation, we used a case-case approach to 
determine whether PAH source exposures were associated with methylation in tumor tissue. 
Tumor subtypes were defined as methylated versus non-methylated. If the gene-specific 
promoter sample size within a stratum was less than 5, it was no longer included in the 
analysis. We explored whether the association between sources of PAH and gene-specific 
promoter methylation varied by hormone receptor status by testing for a multiplicative 
interaction between the PAH source, gene-promoter methylation and ER/PR status of the 
tumor.
For examining global methylation, we first used a controls-only approach to assess whether 
PAH sources were associated with LINE-1 or LUMA measured in control blood samples. 
LINE-1 and LUMA levels were dichotomized based on the distribution in the controls as 
neither LINE-1 nor LUMA were normally distributed before or after natural log 
transformation. We subsequently utilized a case-control approach to assess whether the 
relationship between PAH sources and breast cancer incidence was modified by LUMA 
and/or LINE-1, on a multiplicative scale using both the continuous variable and the 
dichotomized variable. For the study reported here, global methylation assay results among 
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cases are based on blood samples donated prior to chemotherapy (n=79%). Additionally, in 
order to compare our results with previous research (Pirouzpanah et al. 2010; Tao et al. 
2014), we conducted a sensitivity analysis to determine if LUMA was associated with 
wood-burning in the controls and if ever smoking was associated with gene-specific 
methylation in the tumor of cases.
Confounders were identified using a directed acyclic graph (Glymour and Greenland 2008) 
and included age at menarche (<12, ≥12); parity (nulliparous, parous); lifetime alcohol 
intake (non-drinkers, <15g/day, 15–30g/day, ≥30g/day); education (high school graduate or 
less, some college, college graduate); income (<$34,999, $35,000-$69,999, ≥$70,000); and 
the frequency matching factor, 5-year age group.
1.3 Results
1.3.1 Gene-specific promoter methylation in tumor tissue
Results for the associations between each individual source of PAH exposure and the 13 
gene-specific methylation markers are shown in Tables I–V, respectively. ORs greater than 
1 indicate increased odds of methylation and ORs less than 1 indicate decreased odds of 
methylation. There were similarities in associations between the gene-specific DNA 
methylation measured in tumor tissue and the PAH sources (Tables I–V). For example, ORs 
for CCND2 methylation were reduced for residential ETS (Table II; OR=0.65, 
95%CI=0.44–0.96) and perhaps for high grilled/smoked meat intake (Table I; OR=0.69, 
95%CI=0.46–1.06), although confidence intervals for the latter included the null value. ORs 
for RARβ methylation were elevated in association with burning of synthetic logs (Table IV; 
OR=1.80, 95%CI=1.16–2.78) and for high grilled/smoked meat intake (Table I; OR=1.39, 
95%CI=0.94–2.08). ORs for BRCA1 were reduced, indicating hypomethylation in 
association with synthetic logs use (OR=0.44, 95%CI=0.30–0.66), and perhaps with current 
active smoking (OR=0.74, 95%CI= 0.52–1.07), although the confidence intervals for the 
latter included the null value (Tables III and IV, respectively).
Additionally, current active smoking was associated with lower odds of DAPK methylation 
(OR=0.53, 95%CI=0.28–0.99) (Table III) although no other associations with DAPK were 
evident. Lower odds of ESR1 methylation was observed in association with residential ETS 
(OR=0.74, 95%CI= 0.56–0.99) (Table II). Synthetic log use was associated with elevated 
odds of HIN1 methylation (OR=2.14, 95%CI= 1.34–3.42) and CDH1 methylation 
(OR=2.26, 95%CI= 1.06–4.79) (Table IV). Vehicular traffic was associated with higher 
odds of TWIST1 methylation (OR=2.79, 95%CI=1.24–6.30) (Table V).
Ever active smoking, while not included in our a priori exposures of interest, was 
additionally found to be associated with decreased odds of methylation of ESR1 (OR=0.69, 
95%CI 0.52–0.92) and HIN1 (OR=0.66, 95%CI 0.48–0.91) (Appendix Table I). We did not 
observe any evidence of effect measure modification of the association between PAH 
sources and gene-specific methylation by hormone receptor status of the tumor (data not 
shown).
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1.3.2 Global methylation in peripheral blood
Synthetic log use in the home was associated with hypomethylation of LINE-1 in controls 
(OR=0.59, 95%CI=0.41–0.86) and suggestively associated with a pattern of 
hypomethylation in the LUMA assay (OR=0.75, 95%CI=0.52–1.09) (Appendix Table II). 
None of the other PAH sources, including indoor wood burning in a stove or fireplace (data 
not shown), were associated with either LINE-1 or LUMA. We did not observe any 
evidence of effect measure modification of the association between the PAH sources and 
breast cancer incidence by global methylation markers (Appendix Tables III and IV), or 
tumor heterogeneity considering hormone receptor status of the tumor (data not shown) with 
either continuous or dichotomized global methylation variables.
1.3.3 Sensitivity Analyses
For both global and gene-specific analyses, more refined exposure classifications for the 
PAH sources were considered. All results and conclusions remained the same (data not 
shown) and therefore the results for the dichotomized PAH exposure sources were included 
here as they best represented associations and functioned to maximize power.
1.4 Discussion
The sources of PAH exposure examined here were associated with a number of methylation 
sites in both the gene-specific tumor of cases and the blood of controls supporting the 
hypothesis that DNA methylation may be one of the potential biologic mechanisms for the 
association between PAH sources and breast cancer. We considered sources of PAH 
exposure, and classifications of exposure, based on our previous studies (Gammon et al. 
2004a; Mordukhovich et al. 2015; Steck et al. 2007; White et al. 2014) and others (Fu et al. 
2011; Gaudet et al. 2013; Hystad et al. 2015; Morabia 2002), with breast cancer incidence. 
Thus, many of the associations with DNA methylation observed among our population-
based sample of women with breast cancer are biologically plausible and relevant for breast 
carcinogenesis. For example, we observed decreased methylation in the tumor of CCND2, 
an oncogene, in association with residential ETS. Lower methylation at some CpGs in 
CCND2 is correlated with increased mRNA expression in The Cancer Genome Atlas 
(TCGA) breast tumor data (Gao et al. 2013). Conversely, we observed increased 
methylation for RARβ, HIN1 and CDH1 in association with the sources of PAH exposure. 
Both HIN1 and CDH1 are tumor suppressor genes, and increased methylation levels are 
associated with decreased expression of these genes in TCGA data(Gao et al. 2013) . 
Decreased expression of RARβ, a steroid hormone receptor that is important for maintaining 
normal cell growth and regulation, has also been found to play a role in breast 
carcinogenesis (Pirouzpanah et al. 2010). Thus, PAH sources may be both increasing 
expression of oncogenes and repressing expression of tumor suppressor and other genes 
important for normal cell functioning.
We observed that PAH sources were associated with DNA methylation in similar directions 
at certain gene promoter regions, despite differences in exposure source or even route of 
exposure. For example, we reported decreased ORs for methylation at CCND2 for both 
residential ETS and grilled/smoked meat intake. This pattern of findings is supportive of 
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similar biologic mechanisms across the exposure sources. We observed either increased or 
decreased ORs for methylation across different genes, which is consistent with other 
epidemiologic studies of active smoking in healthy individuals that have found associations 
with both increases and decreases in methylation that are site-specific (Zeilinger et al. 2013; 
Zhang et al. 2014). Similarly, a study in breast cancer cell lines found that treatment with the 
PAH compound benzo[a]pyrene (BaP) induces both hyper- and hypomethylation at different 
sites (Sadikovic and Rodenhiser 2006). Although the mechanisms for the association 
between PAHs and DNA methylation are not completely understood, there are a number of 
possible mechanisms by which PAHs may disturb DNA methylation patterns resulting in 
both increases and reductions in methylation levels. There is evidence that a BaP metabolite, 
benzo(a)pyrene diolepoxide (BPDE), has enhanced binding to DNA at methylated CpG sites 
(Yoon et al. 2001) and that DNA methyltransferase bind to DNA lesions with high affinity 
when there is DNA damage such as that from carcinogenic adducts (James et al. 2003). 
Additionally, BPDE can inhibit the function of methyltransferase enzymes resulting in a loss 
of methylation (Wilson and Jones 1984). It is also possible that methylation may be lost 
during the repair of carcinogenic adducts from PAH exposure via the nucleotide excision 
repair pathway (Holliday 1979). Repair of these damaged regions could lead to 
hypomethylation if methylation is not regained prior to DNA replication (Sadikovic and 
Rodenhiser 2006).
In addition to our findings with gene-specific methylation, exposure to burning synthetic 
logs was found to be associated with LINE-1 hypomethylation in the peripheral blood 
among our population-based sample of women without breast cancer. LINE-1 
hypomethylation in the peripheral blood, hypothesized to indicate chromosomal instability 
and increased likelihood for mutations, has been found to be associated with breast cancer in 
a prospective cohort (Deroo et al. 2014), although such an association was not observed in 
the LIBCSP (Xu et al. 2012). BaP has also been found to decrease global methylation in 
vitro (Wilson and Jones 1983). In contrast to our null findings reported here for the LIBCSP 
population, a study conducted in Warsaw, Poland reported an inverse association between 
indoor air pollution measured by wood and coal burning with peripheral blood global 
methylation measured by LUMA (Tao et al. 2014). However, the investigators of the Polish 
study did not consider synthetic log burning which is likely less commonly used in their 
study population.
Several issues regarding our PAH source measures may impact our study interpretation. We 
selected the PAH source variables included here because each was previously reported to be 
most relevant to breast cancer incidence in our study population (Gammon et al. 2004a; 
Mordukhovich et al. 2015; Steck et al. 2007; White et al. 2014). However, other PAH source 
classifications (e.g., ever or former smokers) and other time frames of exposures may also 
be relevant for methylation alterations (Shenker et al. 2013). Our study design limited our 
ability to isolate specific PAH carcinogens, yet the PAH carcinogens found in each exposure 
source are known to vary (Boström et al. 2002). Also, the PAH exposure sources considered 
here contain other chemicals (IARC 2010). These variations across exposure sources, 
however, could be relevant to DNA methylation changes and may be reasons for some 
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discrepancy in patterns across methylated sites among studies and PAH sources (Ruiz-
Hernandez et al. 2015).
In our population-based sample of women, who were ambiently exposed to PAH from 
multiple sources, we were able to consider both gene-specific and global methylation with a 
number of PAH exposure sources, specifically focusing on those which our study team has 
previously found to be associated with breast cancer. We were also able to evaluate potential 
heterogeneity by hormone receptor subtype, as methylation level at a given locus may be 
particularly associated with specific breast cancer tumor subtypes over others (Avraham et 
al. 2014). Consideration of tumor subtype did not alter our conclusions, possibly because the 
LIBCSP study population is predominately women with hormone receptor positive tumors 
and therefore, power to assess associations in receptor negative tumors was limited 
(Gammon et al. 2004a).
Few previous studies have considered associations between tobacco smoke and DNA 
methylation in breast cancer tissue; one study found ever smoking to be associated with 
ESR1 hypermethylation in breast tissue of Iranian women (n=137) (Pirouzpanah et al. 2010), 
which we did not observe when we considered ever active smoking, which we specifically 
examined in order to try and replicate this finding. Differences in active smoking exposure 
history due to geographic and cultural difference between studies may, at least in part, 
explain this discrepancy. Methylation levels may reflect both long-term and recent 
exposures, so it is biologically plausible for variables reflecting different time periods to 
both be relevant (Shenker et al. 2013). Ever active smoking and current active smoking were 
associated with different methylation markers in this study, suggesting that methylation may 
change after stopping smoking (Tsaprouni et al. 2014) or that current smokers may represent 
those with a higher intensity or longer duration of tobacco use and thus may have different 
methylation patterns for that reason. Other studies have focused on white blood cell 
methylation in healthy individuals, although inconsistent associations between air pollution 
and smoking with both gene-specific and global methylation have been observed (Terry et 
al. 2011). However, it is unclear whether global methylation measures accurately reflect that 
of the target tissue (Brooks et al. 2009). Thus, as compared with previous investigations, our 
study expands the specific research questions addressed and the study approach, by utilizing 
a larger population-based study population as well as broadening the scope of the relevant 
PAH sources and DNA methylation targets considered.
We used a panel of a priori genes, and thus, this study cannot rule out that there are other 
methylation sites which could be relevant to PAHs and breast cancer. We did not adjust for 
multiple comparisons; all comparisons made were driven by biologically plausible 
hypotheses and we did not rely on statistical significance for interpretation of measures of 
association and focused on evaluating trends (Savitz and Olshan 1995). However, we cannot 
rule out that some of these associations may be due to chance, because in our study there are 
some instances of low prevalence of methylated genes and small within stratum sizes that 
produced imprecise estimates and may have resulted in over fitting of the models. Regarding 
generalizability, the women in the LIBCSP are predominately white and postmenopausal 
(Gammon et al. 2002), and therefore our results may not be applicable to all women.
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In this first population-based study to report on gene-specific methylation in association 
with current active smoking, residential ETS, synthetic log burning, grilled/smoked meat 
intake and vehicular traffic, we identified biologically plausible associations with aberrant 
DNA methylation in the tumor tissue. DNA methylation represents a potential biologic 
mechanism for environmental chemicals, such as PAH, to influence breast cancer risk.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
Supported in part by grants from the: National Institutes of Health (R25 CA57726, UO1CA/ES66572, 
R01CA109753, 3R01CA109753-04S1, P30CA013696, CA094061, P30ES009089 and P30ES10126); and 
Department of Defense (BC031746 and W81XWH-06-1-0298).
References
Avraham A, Cho SS, Uhlmann R, Polak ML, Sandbank J, Karni T, et al. Tissue specific DNA 
methylation in normal human breast epithelium and in breast cancer. PLoS One. 2014; 9:e91805. 
[PubMed: 24651077] 
Beyea J, Hatch M, Stellman SD, Santella RM, Teitelbaum SL, Prokopczyk B, et al. Validation and 
calibration of a model used to reconstruct historical exposure to polycyclic aromatic hydrocarbons 
for use in epidemiologic studies. Environ Health Perspect. 2006; 114:1053–1058. [PubMed: 
16835058] 
Bjornsson HT, Sigurdsson MI, Fallin MD, Irizarry RA, Aspelund T, Cui H, et al. Intra-individual 
change over time in DNA methylation with familial clustering. JAMA. 2008; 299:2877–2883. 
[PubMed: 18577732] 
Bollati V, Baccarelli A. Environmental epigenetics. Heredity (Edinb). 2010; 105:105–112. [PubMed: 
20179736] 
Boström CE, Gerde P, Hanberg A, Jernstrom B, Johansson C, Kyrklund T, et al. Cancer risk 
assessment, indicators, and guidelines for polycyclic aromatic hydrocarbons in the ambient air. 
Environ Health Perspect. 2002; 110(Suppl 3):451–488. [PubMed: 12060843] 
Brennan K, Flanagan JM. Is there a link between genome-wide hypomethylation in blood and cancer 
risk? Cancer Prev Res (Phila). 2012; 5:1345–1357. [PubMed: 23135621] 
Brooks J, Cairns P, Zeleniuch-Jacquotte A. Promoter methylation and the detection of breast cancer. 
Cancer Causes Control. 2009; 20:1539–1550. [PubMed: 19768562] 
Cho YH, Shen J, Gammon MD, Zhang YJ, Wang Q, Gonzalez K, et al. Prognostic significance of 
gene-specific promoter hypermethylation in breast cancer patients. Breast Cancer Res Treat. 2012; 
131:197–205. [PubMed: 21837480] 
Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-
phenol-chloroform extraction. Anal Biochem. 1987; 162:156–159. [PubMed: 2440339] 
Deroo LA, Bolick SC, Xu Z, Umbach DM, Shore D, Weinberg CR, et al. Global DNA methylation 
and one-carbon metabolism gene polymorphisms and the risk of breast cancer in the Sister Study. 
Carcinogenesis. 2014; 35:333–338. [PubMed: 24130171] 
Duan H, He Z, Ma J, Zhang B, Sheng Z, Bin P, et al. Global and MGMT promoter hypomethylation 
independently associated with genomic instability of lymphocytes in subjects exposed to high-
dose polycyclic aromatic hydrocarbon. Arch Toxicol. 2013; 87:2013–2022. [PubMed: 23543013] 
Eads CA, Danenberg KD, Kawakami K, Saltz LB, Danenberg PV, Laird PW. CpG island 
hypermethylation in human colorectal tumors is not associated with DNA methyltransferase 
overexpression. Cancer Res. 1999; 59:2302–2306. [PubMed: 10344733] 
White et al. Page 11
Environ Res. Author manuscript; available in PMC 2017 February 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, et al. MethyLight: a high-
throughput assay to measure DNA methylation. Nucleic Acids Res. 2000a; 28:E32. [PubMed: 
10734209] 
Eads CA, Lord RV, Kurumboor SK, Wickramasinghe K, Skinner ML, Long TI, et al. Fields of 
aberrant CpG island hypermethylation in Barrett’s esophagus and associated adenocarcinoma. 
Cancer Res. 2000b; 60:5021–5026. [PubMed: 11016622] 
Fu Z, Deming SL, Fair AM, Shrubsole MJ, Wujcik DM, Shu XO, et al. Well-done meat intake and 
meat-derived mutagen exposures in relation to breast cancer risk: the Nashville Breast Health 
Study. Breast Cancer Res Treat. 2011; 129:919–928. [PubMed: 21537933] 
Gammon MD, Neugut AI, Santella RM, Teitelbaum SL, Britton JA, Terry MB, et al. The Long Island 
Breast Cancer Study Project: description of a multi-institutional collaboration to identify 
environmental risk factors for breast cancer. Breast Cancer Res Treat. 2002; 74:235–254. 
[PubMed: 12206514] 
Gammon MD, Eng SM, Teitelbaum SL, Britton JA, Kabat GC, Hatch M, et al. Environmental tobacco 
smoke and breast cancer incidence. Environ Res. 2004a; 96:176–185. [PubMed: 15325878] 
Gammon MD, Sagiv SK, Eng SM, Shantakumar S, Gaudet MM, Teitelbaum SL, et al. Polycyclic 
aromatic hydrocarbon-DNA adducts and breast cancer: a pooled analysis. Arch Environ Health. 
2004b; 59:640–649. [PubMed: 16789472] 
Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex 
cancer genomics and clinical profiles using the cBioPortal. Science signaling. 2013; 6 pl1. 
Gaudet MM, Gapstur SM, Sun J, Diver WR, Hannan LM, Thun MJ. Active smoking and breast cancer 
risk: original cohort data and meta-analysis. J Natl Cancer Inst. 2013; 105:515–525. [PubMed: 
23449445] 
Gibson UE, Heid CA, Williams PM. A novel method for real time quantitative RT-PCR. Genome Res. 
1996; 6:995–1001. [PubMed: 8908519] 
Glymour, MM.; Greenland, S. Modern Epidemiology. 3rd Edition. Philadelphia, PA: Lippincott 
Williams & Wilkins; 2008. Causal Diagrams. 
Hecht SS. Tobacco smoke carcinogens and breast cancer. Environ Mol Mutagen. 2002; 39:119–126. 
[PubMed: 11921179] 
Holliday R. A new theory of carcinogenesis. Br J Cancer. 1979; 40:513. [PubMed: 497103] 
Hystad P, Villeneuve PJ, Goldberg MS, Crouse DL, Johnson K. Exposure to traffic-related air 
pollution and the risk of developing breast cancer among women in eight Canadian provinces: a 
case-control study. Environment international. 2015; 74:240–248. [PubMed: 25454241] 
IARC. Some non-heterocyclic polycyclic aromatic hydrocarbons and some related exposures. (IARC 
monographs on the evaluation of carcinogenic risks to humans / World Health Organization, 
International Agency for Research on Cancer). 1017–1606.IARC Working Group on the 
Evaluation of Carcinogenic Risks to Humans. 2010
James SJ, Pogribny IP, Pogribna M, Miller BJ, Jernigan S, Melnyk S. Mechanisms of DNA damage, 
DNA hypomethylation, and tumor progression in the folate/methyl-deficient rat model of 
hepatocarcinogenesis. J Nutr. 2003; 133:3740S–3747S. [PubMed: 14608108] 
Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nature reviews 
Genetics. 2012; 13:484–492.
Liu ZJ, Maekawa M, Horii T, Morita M. The multiple promoter methylation profile of PR gene and 
ERalpha gene in tumor cell lines. Life Sci. 2003; 73:1963–1972. [PubMed: 12899921] 
Morabia A, Bernstein M, Heritier S, Khatchatrian N. Relation of breast cancer with passive and active 
exposure to tobacco smoke. Am J Epidemiol. 1996:143.
Morabia A. Smoking (active and passive) and breast cancer: Epidemiologic evidence up to June 2001. 
Environ Mol Mutagen. 2002; 39:89–95. [PubMed: 11921174] 
Mordukhovich I, Beyea J, Herring AH, Hatch M, Stellman SD, Teitelbaum S, et al. Exposure to 
Traffic-Related Polycyclic Aromatic Hydrocarbons and Breast Cancer Risk. Environ Health 
Perspect. 2015
Nie J, Beyea J, Bonner MR, Han D, Vena JE, Rogerson P, et al. Exposure to traffic emissions 
throughout life and risk of breast cancer: the Western New York Exposures and Breast Cancer 
(WEB) study. Cancer Causes Control. 2007; 18:947–955. [PubMed: 17632764] 
White et al. Page 12
Environ Res. Author manuscript; available in PMC 2017 February 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Ogino S, Kawasaki T, Brahmandam M, Cantor M, Kirkner GJ, Spiegelman D, et al. Precision and 
performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for 
quantitative DNA methylation analysis. The Journal of molecular diagnostics : JMD. 2006; 8:209–
217. [PubMed: 16645207] 
Pirouzpanah S, Taleban FA, Atri M, Abadi AR, Mehdipour P. The effect of modifiable potentials on 
hypermethylation status of retinoic acid receptor-beta2 and estrogen receptor-alpha genes in 
primary breast cancer. Cancer Causes Control. 2010; 21:2101–2111. [PubMed: 20711807] 
Ruiz-Hernandez A, Kuo C-C, Rentero-Garrido P, Tang W-Y, Redon J, Ordovas JM, et al. 
Environmental chemicals and DNA methylation in adults: a systematic review of the 
epidemiologic evidence. Clin Epigenetics. 2015; 7:55. [PubMed: 25984247] 
Sadikovic B, Rodenhiser DI. Benzopyrene exposure disrupts DNA methylation and growth dynamics 
in breast cancer cells. Toxicol Appl Pharmacol. 2006; 216:458–468. [PubMed: 16926039] 
Savitz DA, Olshan AF. Multiple comparisons and related issues in the interpretation of epidemiologic 
data. Am J Epidemiol. 1995; 142:904–908. [PubMed: 7572970] 
Shenker NS, Ueland PM, Polidoro S, van Veldhoven K, Ricceri F, Brown R, et al. DNA Methylation 
as a Long-term Biomarker of Exposure to Tobacco Smoke. Epidemiology. 2013; 24:712–716. 
[PubMed: 23867811] 
Steck SE, Gaudet MM, Eng SM, Britton JA, Teitelbaum SL, Neugut AL, et al. Cooked meat and risk 
of breast cancer - Lifetime versus recent dietary intake. Epidemiology. 2007:18. [PubMed: 
17179755] 
Tao MH, Zhou J, Rialdi AP, Martinez R, Dabek J, Scelo G, et al. Indoor air pollution from solid fuels 
and peripheral blood DNA methylation: findings from a population study in Warsaw, Poland. 
Environ Res. 2014; 134:325–330. [PubMed: 25199973] 
Terry MB, Zhang FF, Kabat G, Britton JA, Teitelbaum SL, Neugut AI, et al. Lifetime alcohol intake 
and breast cancer risk. Ann Epidemiol. 2006; 16:230–240. [PubMed: 16230024] 
Terry MB, Delgado-Cruzata L, Vin-Raviv N, Wu HC, Santella RM. DNA methylation in white blood 
cells: Association with risk factors in epidemiologic studies. Epigenetics : official journal of the 
DNA Methylation Society. 2011; 6:828–837.
Tsaprouni LG, Yang TP, Bell J, Dick KJ, Kanoni S, Nisbet J, et al. Cigarette smoking reduces DNA 
methylation levels at multiple genomic loci but the effect is partially reversible upon cessation. 
Epigenetics : official journal of the DNA Methylation Society. 2014; 9:1382–1396.
White AJ, Teitelbaum S, Stellman SD, Beyea J, Steck SE, Mordukhovich I, et al. Indoor Air Pollution 
Exposure from Use of Indoor Stoves and Fireplaces in Association with Breast Cancer: A Case-
Control Study. Environmental Health. 2014; 13:108. [PubMed: 25495350] 
Wilson VL, Jones PA. Inhibition of DNA methylation by chemical carcinogens in vitro. Cell. 1983; 
32:239–246. [PubMed: 6825170] 
Wilson VL, Jones PA. Chemical carcinogen-mediated decreases in DNA 5-methylcytosine content of 
BALB/3T3 cells. Carcinogenesis. 1984; 5:1027–1031. [PubMed: 6086166] 
Xu X, Gammon MD, Zhang Y, Bestor TH, Zeisel SH, Wetmur JG, et al. BRCA1 promoter 
methylation is associated with increased mortality among women with breast cancer. Breast 
Cancer Res Treat. 2009; 115:397–404. [PubMed: 18521744] 
Xu X, Gammon MD, Jefferson E, Zhang Y, Cho YH, Wetmur JG, et al. The influence of one-carbon 
metabolism on gene promoter methylation in a population-based breast cancer study. Epigenetics : 
official journal of the DNA Methylation Society. 2011; 6:1276–1283.
Xu X, Gammon MD, Hernandez-Vargas H, Herceg Z, Wetmur JG, Teitelbaum SL, et al. DNA 
methylation in peripheral blood measured by LUMA is associated with breast cancer in a 
population-based study. FASEB journal : official publication of the Federation of American 
Societies for Experimental Biology. 2012; 26:2657–2666. [PubMed: 22371529] 
Yoon J-H, Smith LE, Feng Z, Tang M-s, Lee C-S, Pfeifer GP. Methylated CpG Dinucleotides Are the 
Preferential Targets for G-to-T Transversion Mutations Induced by Benzo [a] pyrene Diol Epoxide 
in Mammalian Cells Similarities with the p53 Mutation Spectrum in Smoking-associated Lung 
Cancers. Cancer Res. 2001; 61:7110–7117. [PubMed: 11585742] 
White et al. Page 13
Environ Res. Author manuscript; available in PMC 2017 February 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Zeilinger S, Kuhnel B, Klopp N, Baurecht H, Kleinschmidt A, Gieger C, et al. Tobacco smoking leads 
to extensive genome-wide changes in DNA methylation. PLoS One. 2013; 8:e63812. [PubMed: 
23691101] 
Zhang Y, Yang R, Burwinkel B, Breitling LP, Brenner H. F2RL3 methylation as a biomarker of 
current and lifetime smoking exposures. Environ Health Perspect. 2014; 122:131–137. [PubMed: 
24273234] 
White et al. Page 14
Environ Res. Author manuscript; available in PMC 2017 February 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Highlights
• We considered the main sources of PAHs, tobacco smoke, diet and indoor/
outdoor air.
• We evaluated methylation in blood of cases and controls and in the tumor of 
cases.
• In controls, burning synthetic logs was associated with lower LINE-1 
methylation.
• In tumor tissue, aberrant methylation was associated with the main PAH 
sources.
• Results suggest methylation may be a biologic mechanism for PAHs and breast 
cancer
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